SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/AF2A6EBC390C88A0C067E943D32F3C149E6E55295BAE4A2B0657A69E2C7A1F681AE5E5285C0BAB9C5D7B0B6D631F3225>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/AF2A6EBC390C88A0C067E943D32F3C149E6E55295BAE4A2B0657A69E2C7A1F681AE5E5285C0BAB9C5D7B0B6D631F3225
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/AF2A6EBC390C88A0C067E943D32F3C149E6E55295BAE4A2B0657A69E2C7A1F681AE5E5285C0BAB9C5D7B0B6D631F3225
http://www.w3.org/2000/01/rdf-schema#comment
"Blocking or knockdown CCN1 expression ameliorated skin inflammation and reduced the expression of CCL20 in both imiquimod and IL-23-induced psoriasis-like mouse models."
xsd:string
http://purl.uniprot.org/uniprot/#_77CAB780C2DC26BC3E10DAE0CF83AF32EC6A6767B7BAF6B473BBFC0FD49BB869FAECEA063BA7F449BFAD059AA85CF1BF
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/AF2A6EBC390C88A0C067E943D32F3C149E6E55295BAE4A2B0657A69E2C7A1F681AE5E5285C0BAB9C5D7B0B6D631F3225
http://purl.uniprot.org/uniprot/O89093
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AF2A6EBC390C88A0C067E943D32F3C149E6E55295BAE4A2B0657A69E2C7A1F681AE5E5285C0BAB9C5D7B0B6D631F3225
http://purl.uniprot.org/uniprot/#_O89093-mappedCitation-28602508
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/AF2A6EBC390C88A0C067E943D32F3C149E6E55295BAE4A2B0657A69E2C7A1F681AE5E5285C0BAB9C5D7B0B6D631F3225